Stephen Shalet

Q: What Schools Are Affiliated With Stephen Shalet

Stephen Shalet is affiliated with the following schools: Queen Mary University of London, University of Manchester

Stephen Shalet's AcademicInfluence.com Rankings

Stephen Shalet

Philosophy

#4091

World Rank

#6480

Historical Rank

Logic

#1631

World Rank

#2433

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Stephen Shalet Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Stephen Michael Shalet is an English endocrinologist, and a former professor at the University of Manchester. Early life He was born in Bedford, where his mother had been evacuated from London. His father was a GP in the East End of London, and serving as an army doctor. At the age of nine he moved to Stoke Newington. He attended Westminster City Grammar School. He studied medicine at the London Hospital, since 1990 the Royal London Hospital, qualifying in 1969.

(See a Problem?)

Stephen Shalet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis (2004) (1607)
Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 (1999) (981)
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. (2000) (756)
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. (1998) (675)
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (1996) (454)
Hypopituitarism following external radiotherapy for pituitary tumours in adults. (1989) (440)
Spermatogenesis after cancer treatment: damage and recovery. (2005) (435)
The diagnosis of growth hormone deficiency in children and adults. (1998) (407)
Gonadal damage from chemotherapy and radiotherapy. (1998) (382)
International Society for Pediatric and Adolescent Diabetes (1998) (374)
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. (2006) (366)
CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline (2006) (345)
Reduced bone mineral density in patients with adult onset growth hormone deficiency. (1994) (336)
RADIATION‐INDUCED HYPOPITUITARISM IS DOSE‐DEPENDENT (1989) (259)
Failure to preserve fertility in patients with Hodgkin's disease (2004) (255)
Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. (1993) (236)
Consensus statement on the management of the GH-treated adolescent in the transition to adult care. (2005) (230)
The effect of combination chemotherapy on ovarian function in women treated for hodgkin's disease (1983) (223)
The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism (1994) (222)
Vulnerability of the human Leydig cell to radiation damage is dependent upon age. (1989) (220)
Gonadal function following chemotherapy for childhood Hodgkin's disease. (1996) (210)
Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. (1989) (209)
THE EFFECT OF VARYING DOSES OF CEREBRAL IRRADIATION ON GROWTH HORMONE PRODUCTION IN CHILDHOOD (1976) (206)
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male (1982) (206)
Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. (1989) (204)
Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. (2001) (203)
Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. (2000) (199)
Endocrine deficit after fractionated total body irradiation. (1992) (197)
Interactions between GH, IGF-I, Glucocorticoids, and Thyroid Hormones during Skeletal Growth (2002) (196)
Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. (2005) (187)
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. (2006) (182)
Optimizing gh therapy in adults and children. (2001) (180)
Does growth hormone cause cancer? (2006) (168)
The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. (2003) (164)
Effect of radiation on the human reproductive system. (1993) (162)
Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. (1979) (160)
Growth hormone treatment of children with brain tumors and risk of tumor recurrence. (2000) (160)
Testicular function following chemotherapy. (2001) (159)
Thyroid Hormones Regulate Hypertrophic Chondrocyte Differentiation and Expression of Parathyroid Hormone‐Related Peptide and Its Receptor During Endochondral Bone Formation (2000) (159)
The assessment of growth hormone status in normal young adult males using a variety of provocative agents (1996) (158)
Endocrine late effects after bone marrow transplant. (2002) (153)
HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. (2007) (152)
Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. (1999) (151)
Effect of spinal irradiation on growth. (1987) (149)
The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. (2004) (147)
Dose dependency of time of onset of radiation-induced growth hormone deficiency. (1991) (136)
Hypopituitarism following radiotherapy (2008) (135)
GROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (1988) (133)
TESTICULAR HISTOLOGY AFTER COMBINATION CHEMOTHERAPY IN CHILDHOOD FOR ACUTE LYMPHOBLASTIC LEUKÆMIA (1978) (132)
The prevalence and characteristics of colorectal neoplasia in acromegaly. (2000) (132)
Leptin binding activity changes with age: the link between leptin and puberty. (1999) (131)
Residual disabilities in children treated for intracranial space‐occupying lesions (1976) (131)
The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood (1996) (128)
Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. (2003) (125)
Gonadal dysfunction due to cis-platinum. (2006) (124)
Biochemical tests in the diagnosis of childhood growth hormone deficiency. (1997) (122)
Molecular mechanisms of thyroid hormone effects on bone growth and function. (2002) (122)
PITUITARY FUNCTION AFTER TREATMENT OF INTRACRANIAL TUMOURS IN CHILDREN (1975) (118)
Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. (1993) (117)
The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index (2009) (116)
Effects of cancer chemotherapy on gonadal function of patients. (1980) (114)
Hypopituitarism following Radiotherapy Revisited. (2009) (114)
Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer (2000) (113)
Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. (2005) (113)
Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. (1982) (111)
Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. (1991) (111)
Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. (2003) (111)
Ovarian failure following abdominal irradiation in childhood. (1976) (111)
Endocrine function following the treatment of acute leukemia in childhood. (1977) (110)
Growth hormone and tumour recurrence. (1992) (108)
Elderly patients with adult-onset growth hormone deficiency are not osteopenic. (1997) (107)
Growth hormone deficiency after treatment of acute leukaemia in children. (1976) (107)
Which adults develop side‐effects of growth hormone replacement? (1995) (107)
Thyroid function after treatment of brain tumors in children. (1991) (106)
Do doctors discuss fertility issues before they treat young patients with cancer? (2008) (101)
Influences on quality of life in GH deficient adults and their effect on response to treatment (1999) (100)
LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE (1990) (99)
CRANIAL IRRADIATION AND EARLY PUBERTY (1993) (98)
Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. (2003) (97)
Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction (2000) (95)
Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. (1999) (95)
Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency (1995) (94)
Growth and puberty after growth hormone treatment after irradiation for brain tumours. (1995) (93)
Radiation and pituitary dysfunction. (1993) (92)
Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. (2002) (92)
Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. (1981) (91)
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. (2003) (91)
The effect of long‐term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH‐deficient adults (2002) (90)
GH-deficient survivors of childhood cancer: GH replacement during adult life. (2002) (90)
DOES GROWTH HORMONE CAUSE RELAPSE OF BRAIN TUMOURS? (1987) (90)
Hypopituitarism As a Consequence of Brain Tumours and Radiotherapy (2006) (89)
Cranial irradiation and early puberty. (1994) (89)
Iodothyronine deiodinase enzyme activities in bone (2008) (88)
Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. (1988) (87)
TESTICULAR FUNCTION FOLLOWING IRRADIATION OF THE HUMAN PREPUBERTAL TESTIS (1978) (87)
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. (2004) (87)
Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood. (1977) (86)
Adults with partial growth hormone deficiency have an adverse body composition. (2003) (84)
Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. (2007) (84)
Effect of cancer therapy on pituitary-testicular axis. (2002) (82)
DISORDERS OF THE ENDOCRINE SYSTEM DUE TO RADIATION AND CYTOTOXIC CHEMOTHERAPY (1983) (81)
Unilateral renal aplasia in X‐linked Kallmann's syndrome (1994) (80)
The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. (2001) (80)
Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. (1990) (79)
Testosterone Deficiency and Replacement (2002) (79)
Circulating insulin-like growth factor II and colorectal adenomas. (2000) (79)
Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. (1996) (78)
Growth impairment in children treated for brain tumours. (1978) (77)
Growth and endocrine function after bone marrow transplantation (1995) (77)
Growth hormone state after completion of treatment with growth hormone. (1987) (77)
The evolution of spinal growth after irradiation. (1991) (76)
ACROMEGALY DUE TO PRODUCTION OF A GROWTH HORMONE RELEASING FACTOR BY A BRONCHIAL CARCINOID TUMOUR (1979) (76)
Leydig cell damage after testicular irradiation for lymphoblastic leukaemia. (1985) (76)
Thyroid hormone actions on cartilage and bone: interactions with other hormones at the epiphyseal plate and effects on linear growth. (1998) (74)
HYPOTHALAMIC GROWTH HORMONE RELEASING FACTOR DEFICIENCY FOLLOWING CRANIAL IRRADIATION (1984) (74)
The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic–pituitary disease (1998) (73)
Primary gonadal damage following treatment of brain tumors in childhood. (1983) (73)
Radiation-Induced Growth Hormone Deficiency (2003) (72)
Aetiology, diagnosis, and management of hypopituitarism in adult life (2006) (72)
Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects (1997) (72)
Body composition in growth hormone deficient adults over the age of 60 years (1996) (72)
Hypopituitarism (2016) (71)
Treatment of growth hormone deficiency in adults. (2000) (70)
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. (1994) (70)
Long-term safety of growth hormone replacement after CNS irradiation. (2011) (70)
Treatment of acromegaly improves quality of life, measured by AcroQol (2007) (69)
Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. (2004) (68)
TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMS (1983) (67)
Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency. (1999) (66)
Fertility preservation and management of gonadal failure associated with lymphoma therapy (2002) (65)
Relationships between insulin‐like growth factor‐1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly (1993) (65)
Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. (2003) (65)
Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly. (2004) (64)
Dose and time relationships in the endocrine response of the irradiated adult rat testis. (1986) (64)
Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. (2005) (64)
Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. (1999) (63)
Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood. (1977) (63)
EFFECT OF SPINAL IRRADIATION ON GROWTH (1986) (62)
Irradiation-induced growth failure. (1986) (60)
A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. (2006) (60)
Low‐dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome (2002) (60)
Quality of life, self‐esteem, fatigue, and sexual function in young men after cancer (2010) (59)
Factors influencing the desire for long‐term growth hormone replacement in adults (1995) (58)
Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer. (1985) (57)
Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. (2000) (57)
Ovarian function following chemotherapy for childhood brain tumours. (1989) (57)
A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. (2003) (56)
LOW‐DOSE PITUITARY IRRADIATION FOR ACROMEGALY (1990) (56)
Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. (2005) (55)
Impact of Growth Hormone Status on Body Composition and the Skeleton (2004) (55)
Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. (2009) (55)
Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. (2005) (54)
Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency. (1999) (54)
ADRENOCORTICOTROPHIN (ACTH) DEFICIENCY UNDETECTED BY STANDARD DYNAMIC TESTS OF THE HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS (1988) (53)
Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat. (2001) (52)
Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. (2007) (51)
Growth hormone replacement throughout life: insights into age-related responses to treatment. (2007) (51)
The impact of dose and route of estrogen administration on the somatotropic axis in normal women. (2003) (51)
Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. (2005) (50)
Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors (2005) (48)
Hypopituitarism after cranial irradiation. (2005) (48)
Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly (2002) (48)
Growth hormone status during long-term hexarelin therapy. (1998) (47)
The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. (2001) (47)
The Effects of Cranial Irradiation on Growth Hormone Secretion (1986) (47)
Growth hormone deficiency in children with brain tumors (1976) (47)
The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. (2005) (46)
The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. (2005) (46)
Endocrine complications of neoplastic diseases in children and adolescents (2001) (45)
Effect of abdominal irradiation on growth in boys treated for a Wilms' tumor. (1990) (45)
Pre‐treatment IGF‐I level is the major determinant of GH dosage in adult GH deficiency (2000) (45)
Radiation and hypothalamic-pituitary function. (1990) (44)
Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. (1997) (43)
Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. (2006) (43)
Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells. (2002) (43)
Screening colonoscopy for acromegaly in perspective* (2001) (42)
THE EFFECTS OF GROWTH HORMONE THERAPY IN CHILDREN WITH RADIATION‐INDUCED GROWTH HORMONE DEFICIENCY (1981) (42)
Growth hormone therapy and malignancy. (1997) (42)
CRANIOPHARYNGIOMA RECURRENCE AND GROWTH HORMONE THERAPY (1988) (41)
Normal testicular function and spermatogenesis (2009) (41)
Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan (2002) (41)
Is maternal growth hormone essential for a normal pregnancy? (1998) (41)
Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly (2001) (40)
Determinants of IGF‐I status in a large cohort of growth hormone‐deficient (GHD) subjects: the role of timing of onset of GHD (2003) (40)
Novel DAX1 mutations in X‐linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism (1999) (40)
The acute leptin response to GH. (2001) (40)
Glucocorticoids, Thyroid Hormone and Growth Hormone Interactions: Implications for the Growth Plate (2002) (40)
Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis. (1990) (39)
Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood (2002) (39)
6 Ageing and growth hormone status (1998) (39)
Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide. (1993) (38)
Insulin sensitivity is impaired in adults with varying degrees of GH deficiency (2005) (38)
Protection of gonadal function from cytotoxic chemotherapy and irradiation. (1990) (38)
DISCORDANT SERUM α‐SUBUNIT AND FSH CONCENTRATIONS IN A WOMAN WITH A PITUITARY TUMOUR (1984) (38)
Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement (1995) (37)
Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. (2002) (37)
IGF‐I, IGF binding protein‐3 and breast cancer risk: Comparison of 3 meta‐analyses (2005) (36)
GLYCOPROTEIN HORMONE α SUBUNIT SECRETION BY PITUITARY ADENOMAS: INFLUENCE OF EXTERNAL IRRADIATION (1980) (36)
Corrigendum: Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (Q J Med (1996) 89 (653-659)) (1996) (35)
Hypothyroidism following childhood cancer therapy–an under diagnosed complication (2012) (35)
Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. (2005) (34)
Bridging the gap: metabolic and endocrine care of patients during transition (2016) (34)
Biochemical Tests in the Diagnosis of Childhood Growth Hormone Deficiency (1997) (34)
Glycoprotein hormone alpha-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine. (1982) (34)
The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients (2001) (34)
Increased Serum Lipoprotein(a) Concentrations after Growth Hormone (GH) Treatment in Patients with Isolated GH Deficiency (1996) (34)
The insulin‐like growth factor‐I generation test: peripheral responsiveness to growth hormone is not decreased with ageing (2003) (33)
Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy (2005) (33)
Radiation and neuroregulatory control of growth hormone secretion (1994) (33)
Effects of Chemotherapy on Bone Metabolism and Skeletal Growth (2002) (33)
How many tests are required to diagnose growth hormone (GH) deficiency in adults? (1999) (33)
Hypothalamic dysfunction in "cured" acromegaly is treatment modality dependent. (1998) (32)
Testicular damage after chemotherapy for childhood brain tumors. (1988) (32)
Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method. (2003) (32)
Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. (2010) (32)
PITUITARY GIGANTISM: A DISABLING CONDITION (1982) (32)
Adult growth hormone replacement: lessons learned and future direction. (2002) (31)
A new sustained‐release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile (2005) (31)
THE PITUITARY‐LEYDIG CELL AXIS IN MEN WITH SEVERE DAMAGE TO THE GERMINAL EPITHELIUM (1987) (31)
The value of IGF1 estimation in adults with GH deficiency. (2009) (31)
Ultrastructural Preservation of Ovarian Cortical Tissue Cryopreserved in Dimethylsulfoxide for Subsequent Transplantation into Young Female Cancer Patients (2004) (31)
Growth response to growth hormone therapy following cranial irradiation (1988) (30)
PROLONGED REMISSION IN FLORID CUSHING'S SYNDROME FOLLOWING METYRAPONE TREATMENT (1981) (30)
The effect of cigarette smoking use and cessation on serum insulin-like growth factors (2004) (30)
Ageing and growth hormone status. (1998) (30)
The evolution of radiation‐induced growth hormone deficiency in adults is determined by the baseline growth hormone status (1995) (29)
Effect of low dose oxandrolone and testosterone treatment on the pituitary‐testicular and GH axes in boys with constitutional delay of growth and puberty (1997) (29)
Differential effects of GH replacement on the components of the leptin system in GH-deficient individuals. (2002) (29)
Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families (1993) (29)
Management of Pituitary Tumours: Strategy for Investigation and Follow-Up (2000) (28)
Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic–pituitary axis (2003) (28)
Treatment of Cushing's disease with low dose radiation therapy. (1984) (28)
GH deficiency and the degree of hypopitultarlsm (1995) (28)
Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. (1998) (28)
Characteristics of adults who wish to enter a trial of growth hormone replacement (1995) (28)
GROWTH AND GROWTH HORMONE RESPONSES TO OXANDROLONE IN BOYS WITH CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY (CDGP) (1988) (28)
Acromegaly and colorectal cancer: risk assessment should be based on population-based studies. (2002) (27)
Bioactive gonadotrophin secretion in man (1991) (27)
The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine. (1993) (26)
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. (2002) (26)
Serum Insulin-Like Growth Factor-I, IGF Binding Protein-3 and IGFBP-3 Protease Activity after Cranial Irradiation (1998) (26)
Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow. (2002) (26)
Growth Hormone Replacement Decreases Plasma Levels of Matrix Metalloproteinases (2 and 9) and Vascular Endothelial Growth Factor in Growth Hormone–Deficient Individuals (2004) (26)
Endocrine sequelae of cancer therapy. (1996) (26)
Diabetes, insulin therapy, and colorectal cancer (2005) (26)
Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency) (2009) (25)
Growth and Growth Hormone Status after a Bone Marrow Transplant (2002) (24)
Effects of GH replacement on metabolism and physical performance in GH deficient adults (2003) (24)
The effect of external pituitary irradiation on elevated serum prolactin levels in patients with pituitary macroadenomas. (1991) (24)
Growth hormone and puberty. (1992) (23)
Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma. (1985) (23)
The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. (2007) (23)
The effect of chronic hexarelin administration on the pituitary–adrenal axis and prolactin (1999) (23)
GROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (1988) (23)
Timing of onset of growth hormone deficiency is a major influence on insulin‐like growth factor I status in adult life (2002) (22)
Testosterone and gonadotrophin profiles in patients on daily or monthly LHRH analogue ICI 118630 (Zoladex) compared with orchiectomy. (1986) (22)
Management of idiopathic growth hormone deficient patients during puberty. (1988) (22)
VALUE OF ROUTINE SERUM-TRIIODOTHYRONINE ESTIMATION IN DIAGNOSIS OF THYROTOXICOSIS (1975) (22)
Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma. (1999) (22)
Treatment of radiation‐induced growth hormone deficiency with growth hormone‐releasing hormone (1997) (22)
Growth and hormonal status of children treated for brain tumours. (1982) (21)
Growth hormone replacement therapy during transition of patients with childhood-onset growth hormone deficiency into adulthood: what are the issues? (1998) (21)
Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima‐medial thickness (2009) (21)
Human chorionic gonadotrophin secreting pineal germinoma and precocious puberty. (1983) (20)
Growth hormone and the transition from puberty into adulthood. (2007) (20)
Growth and Growth Hormone Status following Treatment for Childhood Leukaemia (1998) (20)
PLASMA INHIBIN LEVELS IN MEN WITH CHEMOTHERAPY‐INDUCED SEVERE DAMAGE TO THE SEMINIFEROUS EPITHELIUM (1988) (20)
GH responsiveness varies during the menstrual cycle. (2005) (20)
Urinary growth hormone (GH), insulin-like growth factor I (IGF-I), and IGF-binding protein-3 measurements in the diagnosis of adult GH deficiency. (1998) (20)
Growth response to growth hormone therapy following craniospinal irradiation (2004) (20)
Effects of growth hormone on bone and muscle. (2000) (20)
Effects of growth hormone on boneand muscle (2000) (19)
Growth Impairment Following Treatment for Childhood Brain Tumours (1988) (19)
Tumour occurrence and recurrence. (1992) (19)
The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. (2006) (19)
DISCORDANT RESPONSES OF PROLACTINOMA TO TWO DIFFERENT DOPAMINE AGONISTS (1986) (19)
Spectral pattern complexity analysis and the quantification of voice normality in healthy and radiotherapy patient groups. (2004) (18)
GH replacement reduces increased lipid peroxidation in GH‐deficient adults (2008) (18)
No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B (1995) (18)
RADIATION‐INDUCED HYPERPROLACTINAEMIA IN A TREATED ACROMEGALIC (1979) (17)
Colorectal neoplasia in acromegaly: the reported increased prevalence is overestimated (2000) (17)
Pharmacological protection of the gonads. (1999) (17)
Serum Leptin and Leptin Binding Activity in Children and Adolescents with Hypothalamic Dysfunction (2002) (17)
Pregnancies in women with hyperprolactinaemia: obstetric and endocrinological management of 50 pregnancies in 37 women (1982) (17)
Voice abnormality in adults with congenital and adult-acquired growth hormone deficiency. (2005) (17)
Leydig cell function in the pubertal rat following local testicular irradiation. (1986) (16)
Growth Hormone Pulsatility in Acromegaly Following Radiotherapy (1999) (16)
A new hormonal therapy for prostatic cancer: long-term clinical and hormonal response. (1986) (15)
Adult Panhypopituitarism Presenting as Idiopathic Growth Hormone Deficiency in Childhood (1991) (15)
Relationship between urinary and serum growth hormone and pubertal status. (1992) (15)
SINGLE DAILY DOSE SHORT TERM CARBIMAZOLE THERAPY FOR HYPERTHYROID GRAVES’DISEASE (1983) (15)
Thyroid Hormone and the Growth Plate (2004) (15)
Partial growth hormone deficiency in adults; should we be looking for it? (2010) (15)
Thyroid function in patients with benign and malignant breast disease. (1980) (15)
Growth Hormone and Neurofibromatosis (2000) (15)
Growth hormone therapy for adult growth hormone deficiency (1996) (15)
Growth hormone deficiency and replacement in adults (1996) (14)
Stepping into Adulthood: The Transition Period (2004) (14)
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. (1984) (14)
Puberty in Children with Cancer (2002) (14)
Micronodular adrenal disease: a light and electron microscopic study. (1982) (13)
Spinal irradiation impairs the osteo‐anabolic effects of low‐dose GH replacement in adults with childhood‐onset GH deficiency (2002) (13)
Gonadal function after chemotherapy and irradiation for childhood malignancies. (1988) (13)
Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults. (2005) (13)
Irradiation-induced growth failure. (1986) (13)
Pharmacological treatment of hypercortisolism (2008) (13)
Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro (1998) (13)
Hypothalamic-pituitary disease as the sole manifestation of sarcoidosis (1982) (13)
Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome (1993) (13)
Paradoxical elevations in serum IGF‐II and IGF binding protein‐2 in acromegaly: insights into the regulation of these peptides (2001) (12)
Adolescents with Childhood-Onset GHD: How Do We Get Them to Peak Bone Mass? (2006) (12)
Dose and time related responses of the irradiated prepubertal rat testis. I. Leydig cell function. (1985) (12)
Gonadal function after testicular radiation for acute lymphoblastic leukemia. (1986) (12)
Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other high risk groups (2003) (12)
Growth hormone replacement in adults (1994) (12)
TREATMENT OF CONSTITUTIONAL DELAY IN GROWTH AND PUBERTY (CDGP) (1989) (12)
TESTOSTERONE REDUCES THE BIOACTIVITY OF LUTEINIZING HORMONE (LH) IN MAN (1990) (12)
CHANGES IN THE QUALITATIVE AND QUANTITATIVE SECRETION OF LUTEINIZING HORMONE (LH) FOLLOWING ORCHIDECTOMY IN MAN (1988) (11)
Growth and neuroendocrine consequences (2003) (11)
Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact. (2003) (11)
Leukaemia in Children Treated with Growth Hormone (1993) (11)
Lack of protection by oestrogen from radiation-induced testicular damage in the rat. (1988) (11)
Growth hormone replacement in patients with Langerhan’s cell histiocytosis (1998) (11)
A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1 (2007) (11)
Immune function in hypopituitarism: time to reconsider? (2010) (11)
The Role of Growth Hormone in Stunted Head Growth after Cranial Irradiation (1987) (11)
Transient hypothyroidism after iodine-131 treatment for thyrotoxicosis. (1979) (11)
Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF‐I in adults with severe GH deficiency (GHD) (2009) (11)
Testicular Damage After Chemotherapy for Childhood Brain Tumors (1988) (10)
Conflicts with the sornatopause (1998) (10)
Pituitary adenomas in childhood. (1986) (10)
Acromegaly and colorectal cancer: Risk assessment should be based on population-based studies [4] (multiple letters) (2002) (9)
The Severity of Growth Hormone Deficiency (GHD) in Adult Pituitary Disease is Related to the Degree of Hypopituitarism (1994) (9)
Chemotherapy with actinomycin D influences the growth of the spine following abdominal irradiation. (1992) (9)
Serum somatomedin activity (SMact) in children with acute lymphoblastic leukaemia (ALL) (1978) (9)
Clinical Management of Pituitary Disorders (1980) (9)
Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults (2008) (9)
Seminiferous epithelial function in the pubertal rat following local testicular irradiation. (1986) (9)
Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status (2004) (9)
Cytotoxic Endocrinopathy: A Legacy of Insults (1997) (8)
The stability in vitro of bioactive and immunoreactive LH in human blood and plasma. (1988) (8)
Skeletal requirements for optimal growth hormone replacement in the transitional years. (2003) (8)
Endocrine manipulation of constitutional delay in growth and puberty. (1988) (8)
The use of self-rating questionnaires as a quantitative measure of quality of life in adult growth hormone deficiency. (1999) (8)
Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. (1996) (8)
Adult growth hormone deficiency and bone mass. (1996) (8)
The Insulin-Like Growth Factor I Generation Test in Adults (2005) (8)
THERAPEUTIC CONTROVERSY Treatment of Growth Hormone Deficiency in Adults (2000) (8)
Follicle-stimulating hormone-dependent estrogen secretion by rat Sertoli cells in vitro: modulation by calcium. (1991) (8)
Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement. (1997) (7)
Glycoprotein hormone alpha subunit secretion by pituitary adenomas: influence of external irradiation. (1980) (7)
Defining Growth Hormone Status in Adults with Hypopituitarism (2007) (7)
A new X-linked mental retardation (XLMR) syndrome with late-onset primary testicular failure, short stature and microcephaly maps to Xq25-q26. (2007) (7)
Dose and time related responses of the irradiated prepubertal rat testis. II. Seminiferous epithelial function. (1985) (7)
Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers (2015) (7)
The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. (2007) (7)
Growth hormone outgrows growth (2003) (7)
Pubertal growth in response to testosterone replacement therapy for radiation-induced Leydig cell failure. (1994) (7)
Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. (1999) (7)
Growth hormone and somatomedin levels in acromegalics treated with bromocriptine. (1980) (6)
Treatment of Cushing’s Disease With Low Dose Radiation Therapy (1985) (6)
Difficulties in Patient Management Associated with the Transition Period (2005) (6)
Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist. (2013) (5)
Variation in the core and branch carbohydrate sequences of serum glycoprotein hormone alpha subunit as determined by lectin affinity chromatography. (1984) (5)
EXTERNAL PITUITARY IRRADIATION AS A CAUSE OF TRH DEFICIENCY IN PATIENTS WITH PITUITARY ADENOMAS * (1983) (5)
Radioactive iodine and testicular damage. (1984) (5)
Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement. (2003) (5)
Childhood-onset growth hormone (GH) deficiency in adult life. (2002) (5)
Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness (2009) (5)
QUANTITATIVE AND QUALITATIVE CHANGES IN LH SECRETION FOLLOWING PULSATILE GnRH THERAPY IN A MAN WITH IDIOPATHIC HYPOGONADOTROPHIC HYPOGONADISM (1989) (5)
Hyperhidrosis in acromegaly: effectiveness of topical aluminium chloride hexahydrate solution. (1979) (5)
Serum androgen binding protein and follicle stimulating hormone as indices of Sertoli cell function in the irradiated testis. (1986) (5)
Pregnancy after chemotherapy induced ovarian failure. (1985) (5)
Endocrine-mediated protection from cytotoxic-induced testicular damage. (1989) (5)
Lack of binding of serum glycoprotein hormone alpha subunit to concanavalin A-Sepharose reflects increased branching of the oligosaccharide chains. (1984) (5)
Critical illness as a model of hypothalamic ageing. (2002) (5)
Growth Hormone (GH) Replacement Is Not Justified for All Adults with GH Deficiency (2000) (4)
GH sensitivity of GH‐deficient adults is dependent on gender but not timing of onset (2009) (4)
Gonadal function after allogenic bone marrow transplantation for thalassaemia. (1991) (4)
Growth Hormone Replacement in an Adult with Mild Growth Hormone Deficiency and Hereditary Motor and Sensory Neuropathy: Growth Hormone Restores Independent Mobility (1998) (4)
The modulation of cortisol metabolism by low-dose GH replacement in elderly hypopituitary patients (1998) (4)
Price of survival in childhood leukaemia. (1978) (4)
Replacement therapy should be offered to adults with severe growth hormone deficiency (1997) (3)
Luteinizing hormone pulsatility in men with damage to the germinal epithelium. (1990) (3)
The dynamics of GH secretion in adult cancer survivors with severe radiation-induced GH deficiency (2005) (3)
Cross-sectional study of Quality of Life (QOL) in patients with Acromegaly (2002) (3)
175 INFLUENCE OF AGE AND PUBERTAL STATUS ON RADIATION-INDUCED TESTICULAR DAMAGE IN THE RAT (1985) (3)
Hypothalamic-Pituitary Function following Cranial Irradiation (1979) (3)
Growth hormone deficiency in the elderly. (1997) (3)
Does desensitization to hexarelin occur? (1998) (3)
The Effects of Chemotherapy and Radiotherapy on Testicular Function (2007) (2)
Radiation and Hypothalamic Pituitary Function (1994) (2)
Conflicts with the somatopause. (1998) (2)
VULNERABILITY OF THE HUMAN LEYDIG CELL TO RADIATION DAMAGE IS AGE-DEPENDENT (1986) (2)
Growth hormone (GH) replacement therapy: cancer in children receiving GH. (2000) (2)
Growth hormone therapy following bone marrow transplantation in childhood. (1991) (2)
Evaluation and Management of Late Effects of Cancer Treatment (2010) (2)
Growth hormone in adults: Monitoring growth hormone replacement therapy (2000) (2)
HYPOTHALAMIC/PITUITARY AXIS AND TREATMENT OF LEUKÆMIA (1976) (2)
Endocrine Tumours: The Pathobiology of Regulatory Peptide-Producing Tumours (1986) (2)
Prospects for the Development of Long-Acting Formulations of Human Somatropin (2006) (2)
Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults. (2011) (2)
Recent Results in Cancer Research: Thyroid Cancer (1981) (2)
Male Hypogonadism Resulting From Cancer and Cancer Treatments (2004) (1)
The price of survival in childhood leukaemia. (1978) (1)
Testicular function and morphology after chemotherapy in childhood for ALL (1979) (1)
HYPERTENSION AND PLASMA RENIN ACTIVITY IN WOMEN WITH TURNER SYNDROME (2003) (1)
Testicular function after chemotherapy for acute lymphoblastic leukemia. (1981) (1)
Cigarette smoking exposure, serum insulin-like growth factors, and cancer risk: A population-based study (2002) (1)
Childhood Brain Tumours and Growth Hormone Treatment (2007) (1)
Evolving therapeutic strategies for acromegaly (2001) (1)
Chapter 14 – Does Desensitisation to Growth Hormone Secretagogues Occur? (1999) (1)
Elevated serum alpha subunit levels in patients with cancer; a consequence of gonadotrophin secretion and age. (1987) (1)
Subject Index Vol. 53, Suppl. 3, 2000 (2000) (1)
Growth hormone therapy for adult growth hormone deficiency. (1998) (1)
Endocrine consequences of childhood cancer treatment in adult life (2001) (1)
PATIENTS AT RISK OF HYPOTHYROIDISM (1977) (1)
Dose Titration and Monitoring GH Treatment in the Adult (1999) (1)
Pituitary hormone replacement (2001) (1)
Diagnosis of adrenal insufficiency (1989) (1)
60 years on, growth hormone inches its way to safety. (2020) (1)
A densitometric and architectural analysis of the skeleton in adults with varying degrees of GH deficiency (2005) (1)
Carotid arterial intima-media thickness (IMT), a marker of atherosclerosis, does not differ in patients with acromegaly compared to healthy controls (2006) (1)
Plasma Growth Hormone (GH) Responses to Growth Hormone Releasing Factor (hp GRF 1–44) in Familial GH Deficiency (1987) (1)
CLINICAL PERSPECTIVE Adult Growth Hormone Replacement: Lessons Learned and Future Direction (2002) (1)
A practical approach to the investigation of the hyperprolactinaemic patient. (1981) (1)
LOW DOSE OXANDROL ONE THERAPY IN CONSTITUTIONALLY DELAYED GROWTH (1988) (1)
Serum Follicle Stimulating Hormone, Androgen Binding Protein, and Regeneration of the Seminiferous Epithelium after Local Testicular Irradiation (1984) (1)
HOW TO OPTIMISE PEGVISOMANT TREATMENT OF ACROMEGALY SAFELY (2002) (1)
The influence of a GH receptor antagonist (GHRA) on the relationship between GH and IGF-I in Adults with Growth Hormone Deficiency (AGHD) (2006) (0)
Growth and Development in Children Treated for Cancer: European Society on Paediatric Endocrinology, ESPE-Symposium, 27th Annual Meeting, Copenhagen 1988 (1989) (0)
Central hypothyroidism and adjusted thyroxine dose study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism (2013) (0)
Autotransplantation of ovarian tissue (2001) (0)
GONADAL DYSFUNCTION AFTER NITROSOUREA CHEMOTHERAPY (CIX) FOR CHILDHOOD BRAIN TUMOURS (1988) (0)
Testicular dysfunction after combination chemotherapy for Hodgkin's disease in childhood (1981) (0)
How do Changes in the GH/IGF-1 Status of the Elderly Occurring Naturally, Pathologically or Therapeutically-Induced Impact on their Lives (2004) (0)
Interpreting results: a Clinician's perspective (2009) (0)
The role of Inhibin in the control of the prepubertal hypothalamic-pituitary testicular-axis (1978) (0)
Neuroendocrinology: a Clinical Text (1987) (0)
Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults. (2000) (0)
Growth Response to GH therapy in Children with Radiation-Induced GH deficiency (1981) (0)
Quality of life (QOL) improvement, during physiological GH replacement in severely GHD adults, is not explained by favourable changes in body composition (2004) (0)
Clinics in Endocrinology and Metabolism (1978) (0)
Endocrine Aspects of Acute Illness (1985) (0)
Responsiveness to growth hormone throughout the menstrual cycle (2004) (0)
HEAD GROWTH AND GROWTH HORMONE (GH) THERAPY FOLLOWING CRANIAL IRRADIATION (1988) (0)
Partial GH deficiency is associated with an adverse serum lipid profile (2005) (0)
TITLE: Acquired prolactin deficiency (APD) reflects residual pituitary function after treatment for Cushing's disease (2003) (0)
Growth hormone sensitivity in GH deficient (GHD) hypopituitary adults is dependent on gender, but independent of timing of onset (2007) (0)
Pathology Detection - Spectral Entropy Signature of Speech Perturbation in Adult Acquired Growth Hormone Deficiency (2003) (0)
Adrenal and Endocrine Tumours in Children. Cancer Treatment and Research Series (1984) (0)
Endocrine manifestations of cancer and its treatment. (1981) (0)
OR03-6 Intranasal administration of Human Growth Hormone (CP024) and induction of IGF-1 in healthy volunteers (2012) (0)
The use of AcroQol to re-evaluate quality of life (QOL) in patienits with acromegaly (2007) (0)
Growth hormone replacement treatment in adult patients (1996) (0)
FINAL STATURE AFTER GROWTH HORMONE (GH) THERAPY IN RADIATION-INDUCED GH DEFICIENCY (1988) (0)
Endocrine aspects of cancer (1994) (0)
UK stance on adult GH replacement maintains our isolation from Europe (2012) (0)
Contents, Vol. 34, 1990 (1990) (0)
Discordant stimulated growth hormone (GH) responses in cranially irradiated adult cancer survivors may occur in the presence of normal GH status: compensated GH deficiency (2008) (0)
Can Adults with severe Growth Hormone Deficiency (AsGHD) and a low IGF-I be distinguished from those with a normal IGF-I? (2006) (0)
A new sustained-release preparation of human growth hormone: pharmacokinetic, pharmacodynamic and safety profile (2005) (0)
Subject Index, Vol. 34, 1990 (1990) (0)
Mortality and morbidity in adult life as a consequence of radiation-induced growth hormone deficiency in childhood (2001) (0)
Cancer Survivors-the New Endocrine Epidemic (2017) (0)
Paediatric Neuroendocrinology (1985) (0)
The hydration fraction of lean body mass (LBM) does not change during six months physiological GH replacement in adults with severe GHD (2004) (0)
Reproducibility of cortisol day curve in monitoring patients on long-term Hydrocortisone Replacement Therapy (2004) (0)
REASSESSMENT OF GROWTH HORMONE STATUS IS REQUIRED AT FINAL HEIGHT IN CHILDREN TREATED WITH GROWTH HORMONE REPLACEMENT FOLLOWING RADIATION THERAPY (2003) (0)
Care of childhood cancer survivors (2023) (0)
Effect of long-term untreated GH deficiency (GHD) and nine years of GH replacement on the quality of life (QoL) of GHD adults (2001) (0)
Growth hormone treatment does not decrease homocysteine levels (2002) (0)
The type II and III iodothyronine deiodinase enzymes are expressed in differentiating growth plate chondrocytes (2003) (0)
childhood . derived growth hormone therapy in Creutzfeldt-Jakob disease after pituitary Neurosurgery in a patient with (2003) (0)
Article is After Cancer Treatment: Damage and Recovery (2005) (0)
Changes in thyroid function in survivors of brain tumours followed longitudinally (2005) (0)
Choosing a collaborator (2000) (0)
Endocrine Problems in Cancer; Molecular Basis and Clinical Management (1985) (0)
Subject Index Vol. 62, Suppl. 3, 2004 (2004) (0)
Subject Index Vol. 62, Suppl. 3, 2004 (2004) (0)
Quality of Life in Adult Growth Hormone Deficiency (2006) (0)
The challenges of implementing consensus recommendations for GH therapy in GHD adolescent survivors of childhood cancer during the transition period (2009) (0)
Influence of age on the vulnerability of the hypothalamic-pituitary axis to radiation damage (2002) (0)
Tumours of the Endocrine Glands (1986) (0)
Mild hypogonadism and osteopaenia (1993) (0)
Insulin-like Growth Factor (IGF)-II Peptide Overexpression Early in the Adenoma-Carcinoma Sequence. (2001) (0)
ENDOCRINE OUTCOME (1993) (0)
Continuation of GH treatment for growth hormone deficiency after adolescence (1998) (0)
Childhood Cancer, Endocrine Effects of (2004) (0)
Primary therapy with somatostatin analogues in acromegaly does not restore orderly GH secretion (2004) (0)
Multiple endocrine neoplasia Type 1 (MEN1) caused by a novel mutation in intron 9 in a family with the McCune-Albright syndrome (2007) (0)
16th Paterson Symposium—Cellular mechanisms of long-term injury in tissue after radiation (1982) (0)
Letter: Hypothalamic/pituitary axis and treatment of leukemia. (1976) (0)
THE ASSOCIATION OF THE EMPTY SELLA SYNDROME WITH ADVERSE PERINATAL EVENTS IN IDIOPATHIC GROWTH HORMONE DEFICIENCY (1986) (0)
Growth Hormone Replacement Decreases Plasma Levels of Matrix Metalloproteinases (2 and 9) and Vascular Endothelial Growth Factor in Growth Hormone–Deficient Individuals Clinical Investigation and Reports (2004) (0)
Optimising treatment of early puberty in survivors of childhood cancer (2007) (0)
Hypothalamic-pituitary (h-p) irradiation resets the osmostat with upward shift in plasma osmolality (2002) (0)
Clinical Endocrinology Trust Lecture (2003) (0)
Changes in plasma inhibin levels following pulsatile gonadotrophin-releasing hormone therapy in a man with idiopathic hypogonadotrophic hypogonadism. (1990) (0)
Quality of Life (QoL) and IGF-I Status in Adults with Severe GHD (2016) (0)
P-87 IGF-I:IGFBP-3 molar ratio and disease risk: statistical considerations and level of agreement with free IGF-I (2008) (0)
Time dependency of somatotroph dysfunction following radiation damage of the hypothalamic-pituitary axis (2002) (0)
Subject Index, Vol. 39, 1993 (1993) (0)
Testicular function after combination chemotherapy (2006) (0)
Residual adverse vascular risk and oxidative stress in treated adult panhypopituitarism (2008) (0)
Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease--being aware of diagnostic features 25 years later. (2009) (0)
Contents, Vol. 39, 1993 (1993) (0)
Subject Index Vol. 58, Suppl. 1, 2002 (2002) (0)
THE IGF-1 GENERATION TEST IN ADULTS : DOSE RESPONSE TO AN ACUTE BOLUS OF GROWTH HORMONE IN NORMAL HEALTHY VOLUNTEERS (2002) (0)
Late endocrine effects after treatment for nasopharyngeal cancer (2005) (0)
BRIEF REPORT Voice Abnormality in Adults with Congenital and Adult- Acquired Growth Hormone Deficiency (2005) (0)
Spontaneous GH secretion in the fed and fasting states in cranially irradiated adult cancer survivors with normal peak GH responses to two provocative tests: does GH neurosecretory dysfunction exist? (2006) (0)
Loss of examination status (2000) (0)
Endocrine manipulation to treat aggressive angiomyxoma (2008) (0)
OR12-5 LONG-TERM RESPONSE OF SPECIFIC QUALITY OF LIFE (QOL) DIMENSIONS TO GROWTH HORMONE (GH) REPLACEMENT IN ELDERLY PATIENTS WITH GH DEFICIENCY (GHD) (2006) (0)
IGF-I; IGF-binding protein-3 and breast cancer risk (2005) (0)
Cancer treatment endocrinopathies and growth hormone status throughout life (2021) (0)
IGF-1, IGFBP-3, and cancer risk (2004) (0)
Workshop 3: Growth hormone deficiency after head trauma and cranial irradiation (2004) (0)
Adults with partial GH deficiency (GHD) show phenotypic dichotomy related to the timing of onset of the deficiency (2010) (0)
Reduced bone density in patients with growth hormone deficiency (GHD) of adult onset (1993) (0)
The cardiovascular risk profile and carotid IMT of adults with partial GH deficiency (2006) (0)
Growth hormone (GH) deficient survivors of childhood cancer: the role of GH replacement during adult life (2001) (0)
Randomised placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency (2001) (0)
Endocrine Problems in Cancer; Molecular Basis and Clinical Management (1985) (0)
Experience with cabergoline therapy in 34 patients with acromegaly (2002) (0)
Silent Corticotroph Adenomas (2011) (0)
GONADALFUNCTION AFTER FRACTIONATED TOTAL BODY IRRADIATION (TBI) (1993) (0)
The GP's role in growth hormone deficiency. (2000) (0)
UK stance on adult growth hormone replacement: the Economist versus the (2013) (0)
Severe growth hormone (GH) deficiency: One test VS two tests — The evidence (1998) (0)
GROWTH HORMONE SECRETION ON COMPLETION OF TREATMENT IN ISOLATED “IDIOPATHIC” AND POST-IRRADIATION GROWTH HORMONE DEFICIENCY (1986) (0)
21 THE EFFECTS OF CRANIAL IRRADIATION ON GROWTH HORMONE SECRETION (1985) (0)
Increased fat mass may be protective of bone mass in young male cancer survivors (2010) (0)
27 YEARS ON - IMPROVED FINAL HEIGHT WITH GROWTH HORMONE THERAPY AFTER IRRADIATION FOR CHILDHOOD BRAIN TUMOURS REFLECTING EVOLVING ENDOCRINE PRACTICE (2002) (0)
34 Treatment of advanced prostatatic carcinoma with lhrh-analogue ICI 118 630 (1983) (0)
The nature of the quality of life (QOL) impairment in adult GHD survivors of cancer and their response to GH replacement therapy (2003) (0)
Subject Index Vol. 64, Suppl. 2, 2005 (2005) (0)
Hypothyroidism in adult survivors of childhood malignancy (2009) (0)
Treatment of childhood cancer: effects on gonads. (1978) (0)
A novel finding of activation of the hypothalamic-pituitary-adrenal axis with increased cortisol production rates and circulating cortisol concentrations in 24-hour profiling study in cranially irradiated adult cancer survivors (2005) (0)
Clues to aetiology of testicular germ cell tumours from descriptive epidemiology. Discussion (1993) (0)
Growth hormone (GH) status following cure of cushing's disease (1998) (0)
Clinical Endocrinology Trust/Royal Society of Medicine Visiting Professor (1989) (0)
Lack of influence of an IGF-I gene polymorphism on circulating IGF-I levels in severely GHD adults (2006) (0)
Tumours of the Endocrine Glands in Children. (1994) (0)
Does the adverse lipid profile in humans with severe GHD worsen from childhood to adult life (2001) (0)
A case of adrenal failure secondary to metastasis from a breast angiosarcoma (2004) (0)
OR2,4 The development of multi-dimensional models of serum IGF-I, -II, IGFBP-2 and -3 using artificial neural networks as “composite biomarkers” to predict colorectal cancer (2008) (0)
Apractical approach totheinvestigation ofthehyperprolactinaemic patient (1981) (0)
Spectral entropy signature of speech perturbation in adult acquired growth hormone deficiency (2003) (0)
Responsiveness to growth hormone (GH) is increased in obesity (2004) (0)
Circadian and pulsatile secretion of copeptin, an arginine vasopressin (AVP) marker, argues against a physiological role of AVP in cortisol release (2010) (0)
Baillière's Clinical Endocrinology and Metabolism: International Practice and Research. Vol. 1, No. 1, Feb. 1987. Reproductive Endocrinology (1988) (0)

This paper list is powered by the following services:

Other Resources About Stephen Shalet

en.wikipedia.org

What Schools Are Affiliated With Stephen Shalet?

Stephen Shalet is affiliated with the following schools: